Segurança do uso de PMMA em técnicas reparadoras de cranioplastia: revisão de revisões sistemáticas
Vigilância Sanitária em Debate · 11.08.2026 · 1-10
DOI: 10.22239/2317-269x.02638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vigilância Sanitária em Debate, online erschienen am 11.08.2026. Verfasst von Erika Barbosa Camargo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Polymethylmethacrylate (PMMA) is a biomaterial widely used in cranioplasty due to its low cost, ease of intraoperative molding, and adequate structural stability. However, the occurrence of infectious complications and other clinical adverse events makes a systematic assessment of its safety profile in cranial reconstruction necessary.
Objective
To analyze the safety profile and adverse events associated with the use of PMMA in reconstructive cranioplasty techniques.
Method
An overview of systematic reviews was conducted according to Cochrane recommendations and reported following PRISMA guidelines. The search was performed on March 4, 2026, in six electronic databases: Medline via PubMed, Embase via Elsevier, Cochrane Library, Regional Portal of the Virtual Health Library (BVS), Web of Science, and Scopus, with a complementary search in Google Scholar. Systematic reviews with or without meta-analysis that evaluated the use of PMMA in cranioplasty and reported safety outcomes were included.
Results
A total of 109 systematic reviews were identified, of which 10 were included. Adverse events associated with PMMA in cranioplasty were mainly related to local and infectious complications. Among mild local events, erythema, local edema, pruritus, and ecchymosis were the most frequently reported, described as common (10–50%). Moderate local events included superficial infection in 10.47% and implant-related infections (superficial or deep) with frequencies of 14.9%, 7.8%, and 8.0%. Severe local events included intracranial granuloma due to foreign body reaction and implant migration or displacement, with frequencies of 3.72%, 2.3%, and 2.0%. Systemic events included seizures and postoperative neurological complications, with frequencies of up to 15.6%.
Conclusions
The safety profile of PMMA demonstrated a relevant risk of infection and the occurrence of severe adverse events, although rare. The choice of material should be individualized, considering the patient risk profile, the complexity of the cranial defect, and the availability of alternative materials. The predominance of retrospective studies and methodological heterogeneity highlight the need for randomized clinical trials to strengthen the evidence on the long-term safety and effectiveness of PMMA.
Zitieren
APA
Camargo, E. B., Puga, M. E., Pereira, V. C., & Elias, F. T. S. (2026). Segurança do uso de PMMA em técnicas reparadoras de cranioplastia: revisão de revisões sistemáticas. Vigilância Sanitária em Debate, 1-10. https://doi.org/10.22239/2317-269x.02638
Vancouver
Camargo EB, Puga ME, Pereira VC, Elias FTS. Segurança do uso de PMMA em técnicas reparadoras de cranioplastia: revisão de revisões sistemáticas. Vigilância Sanitária em Debate. 2026:1-10. doi:10.22239/2317-269x.02638
BibTeX
@article{Camargo2026,
author = {Camargo, Erika Barbosa and Puga, Maria Eduarda and Pereira, Viviane Cássia and Elias, Flávia Tavares Silva},
title = {Segurança do uso de PMMA em técnicas reparadoras de cranioplastia: revisão de revisões sistemáticas},
journal = {Vigilância Sanitária em Debate},
year = {2026},
pages = {1--10},
doi = {10.22239/2317-269x.02638}
}
EUVIMED